首页> 外文期刊>Molecular and Cellular Biochemistry: An International Journal for Chemical Biology >Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells
【24h】

Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells

机译:信号传感器和转录激活剂3和5调节人乳腺癌细胞中的系统XC-和氧化还原平衡

获取原文
获取原文并翻译 | 示例
       

摘要

System Xc- is a cystine/glutamate antiporter that contributes to the maintenance of cellular redox balance. The human xCT (SLC7A11) gene encodes the functional subunit of system Xc-. Transcription factors regulating antioxidant defense mechanisms including system Xc- are of therapeutic interest, especially given that aggressive breast cancer cells exhibit increased system Xc- function. This investigation provides evidence that xCT expression is regulated by STAT3 and/or STAT5A, functionally affecting the antiporter in human breast cancer cells. Computationally analyzing two kilobase pairs of the xCT promoter/5' flanking region identified a distal gamma-activated site (GAS) motif, with truncations significantly increasing luciferase reporter activity. Similar transcriptional increases were obtained after treating cells transiently transfected with the full-length xCT promoter construct with STAT3/5 pharmacological inhibitors. Knock-down of STAT3 or STAT5A with siRNAs produced similar results. However, GAS site mutation significantly reduced xCT transcriptional activity, suggesting that STATs may interact with other transcription factors at more proximal promoter sites. STAT3 and STAT5A were bound to the xCT promoter in MDA-MB-231 cells, and binding was disrupted by pre-treatment with STAT inhibitors. Pharmacologically suppressing STAT3/5 activation significantly increased xCT mRNA and protein levels, as well as cystine uptake, glutamate release, and total levels of intracellular glutathione. Our data suggest that STAT proteins negatively regulate basal xCT expression. Blocking STAT3/5-mediated signaling induces an adaptive, compensatory mechanism to protect breast cancer cells from stress, including reactive oxygen species, by up-regulating xCT expression and the function of system Xc-. We propose that targeting system Xc- together with STAT3/5 inhibitors may heighten therapeutic anti-cancer effects.
机译:系统XC-是一种胱氨酸/谷氨酸抗原剂,有助于维持细胞氧化还原平衡。人XCT(SLC7A11)基因编码系统XC-的功能亚基。调节包括系统XC的抗氧化防御机制的转录因子是治疗兴趣的,特别是鉴于侵袭性乳腺癌细胞表现出增加的系统XC功能。本研究提供了证据,即XCT表达由STAT3和/或Stat5a调节,在功能上影响人乳腺癌细胞中的抗抗原剂。计算地分析XCT启动子/ 5'侧翼区域的两千碱基对鉴定了远端γ-活化位点(气体)基序,截断显着增加了荧光素酶报告活性。在用STAT3 / 5药理抑制剂用全长XCT启动子构建体瞬时转染后,获得了类似的转录增加。 STAT3或Stat5a的敲击与siRNA产生类似的结果。然而,气体位点突变显着降低了XCT转录活动,表明统计数据可以与更多近端启动子位点的其他转录因子相互作用。 STAT3和Stat5a与MDA-MB-231细胞中的XCT启动子结合,通过用统计抑制剂预处理破坏结合。药理学抑制STAT3 / 5激活显着增加XCT mRNA和蛋白质水平,以及胱氨酸摄取,谷氨酸释放和细胞内谷胱甘肽的总水平。我们的数据表明Stat蛋白对基底XCT表达产生负面调节。阻断STAT3 / 5介导的信号传导诱导自适应的补偿机制,以保护乳腺癌细胞免受应力,包括反应性氧物种,通过上调XCT表达和系统XC-的功能。我们提出靶向系统XC-与STAT3 / 5抑制剂一起可以提高治疗性抗癌作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号